SHANNON SHEETS: Open Payments
NPI 1295308716 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 19 payments from 11 companies in 2025. Trend: 2023 $146 · 2024 $140 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $114 |
| Incyte Corporation | 2 | $48 |
| PFIZER INC. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| JAZZ PHARMACEUTICALS INC. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Syndax Pharmaceuticals, Inc. | 1 | $22 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $21 |
| Apellis Pharmaceuticals, Inc. | 1 | $21 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
Products named: VENCLEXTA, IMBRUVICA, ELREXFIO, LIVTENCITY, RYLAZE, Vanflyta, EPKINLY, JAKAFI.
Industry payments across CO — which companies pay providers there.
